Title | A spatial long-read approach at near-single-cell resolution reveals developmental regulation of splicing and polyadenylation sites in distinct cortical layers and cell types. |
Publication Type | Journal Article |
Year of Publication | 2025 |
Authors | Foord C, Prjibelski AD, Hu W, Michielsen L, Vandelli A, Narykov O, Evans B, Hsu J, Belchikov N, Jarroux J, He Y, M Ross E, Hajirasouliha I, Tartaglia GGaetano, Korkin D, Tomescu AI, Tilgner HU |
Journal | Nat Commun |
Volume | 16 |
Issue | 1 |
Pagination | 8093 |
Date Published | 2025 Aug 29 |
ISSN | 2041-1723 |
Keywords | Adolescent, Alternative Splicing, Child, Exons, Female, Gene Expression Regulation, Developmental, Humans, Male, Neurons, Oligodendroglia, Polyadenylation, Single-Cell Analysis, Visual Cortex, White Matter, Young Adult |
Abstract | Genome-wide spatial long-read approaches often lack single-cell resolution and yield limited read lengths. Here, we introduce spatial ISOform sequencing (Spl-ISO-Seq), which reveals exons and polyadenylation sites with near-single-cell resolution. Spl-ISO-Seq selects long cDNAs and doubles to triples read lengths compared to standard preparations. Adding a highly specific software tool (Spl-ISOquant) and comparing human post-mortem pre-puberty (8-11 years) to post-puberty (16-19 years) visual cortex samples, we find that cortex harbors stronger splicing and poly(A)-site regulation than white matter. However, oligodendrocyte regulation is stronger in white matter. Among cortical layers, layer 4 has the most developmentally-regulated splicing changes in excitatory neurons and in poly(A) sites. We also find repeat elements downstream of developmentally-regulated layer 4 exons. Overall, alternative splicing changes are linked to post-synaptic structure and function. These results root developmental splicing changes during puberty in specific layers and cell types. More generally, our technologies enable exciting observations for any complex tissue. |
DOI | 10.1038/s41467-025-63301-9 |
Alternate Journal | Nat Commun |
PubMed ID | 40883294 |
PubMed Central ID | PMC12397408 |
Grant List | MIRA R35 GM152101-01 / / U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) / R01 GM135247 / GM / NIGMS NIH HHS / United States R35 GM152101 / GM / NIGMS NIH HHS / United States 851093, SAFEBIO / / EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) / U01 DA053625-01 / / U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) / U01 DA053625 / DA / NIDA NIH HHS / United States 2T32DA039080 / / U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) / R01 HD111089 / HD / NICHD NIH HHS / United States T32 DA039080 / DA / NIDA NIH HHS / United States R01HD111089 / / U.S. Department of Health & Human Services | National Institutes of Health (NIH) / RF1 MH121267 / MH / NIMH NIH HHS / United States 1R01LM014017-01 / / U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) / R35 GM138152 / GM / NIGMS NIH HHS / United States No. 851093, SAFEBIO / / EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) / GRFP # 2139291 / / National Science Foundation (NSF) / 1R01GM135247-01 / / U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) / R01 LM014017 / LM / NLM NIH HHS / United States |